Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation

Outcomes for diffuse large B-cell lymphoma (DLBCL) patients relapsing after autologous hematopoietic cell transplantation (auto-HCT) have been historically poor. We studied outcomes of such patients using data from 4 transplantation centers. Eligibility criteria included adult patients (age ≥18 year...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Epperla, Narendranath, Badar, Talha, Szabo, Aniko, Vaughn, John, Borson, Steve, Saini, Neeraj Y., Patel, Romil D., Shah, Nirav N., Hamadani, Mehdi, Ahmed, Sairah, Cashen, Amanda F., Fenske, Timothy S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2019
Ämnen:
Lymphoid Neoplasia
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560348/
https://ncbi.nlm.nih.gov/pubmed/31167818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000102
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk